| Name | 4-chloro-N,N,6-trimethylpyrimidin-2-amine |
|---|---|
| Synonyms |
4-dimethylamino-2-chloro-6-methylpyrimidine
4-Chloro-N,N,6-trimethyl-2-pyrimidinamine 4-Chloro-2-dimethylamino-6-methylpyrimidin 4-chloro-2-dimethylamino-6-methylpyrimidine (4-chloro-6-methyl-pyrimidin-2-yl)-dimethyl-amine (4-Chlor-6-methyl-pyrimidin-2-yl)-dimethyl-amin EINECS 227-243-7 |
| Density | 1.207g/cm3 |
|---|---|
| Boiling Point | 272.1ºC at 760mmHg |
| Melting Point | 35-36ºC |
| Molecular Formula | C7H10ClN3 |
| Molecular Weight | 171.62700 |
| Flash Point | 118.4ºC |
| Exact Mass | 171.05600 |
| PSA | 29.02000 |
| LogP | 1.50440 |
| Index of Refraction | 1.567 |
| HS Code | 2933599090 |
|---|
|
~%
5734-62-3 |
| Literature: TAISHO PHARMACEUTICAL CO., LTD.; Arena Pharmaceuticals, Inc Patent: WO2005/95357 A2, 2005 ; Location in patent: Page/Page column 137; 138 ; WO 2005/095357 A2 |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |